HERC2: A Promising Biomarker in Ovarian Cancer
In the realm of oncology, identifying reliable biomarkers for disease prognosis and treatment response is crucial for personalized medicine. The ...
In the realm of oncology, identifying reliable biomarkers for disease prognosis and treatment response is crucial for personalized medicine. The ...
A groundbreaking Phase 3 clinical trial, KEYNOTE-426, has delivered compelling evidence that a combination of pembrolizumab and axitinib significantly enhances ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine